Safety and Immunogenicity of SCB-2019 in Children <18 Years of Age (clinicaltrials.gov) - Mar 24, 2023 - P2/3 | N=0 | Withdrawn | Sponsor: Clover Biopharmaceuticals AUS Pty Ltd | N=3820 ➔ 0 | Trial completion date: Jul 2024 ➔ Dec 2022 | Not yet recruiting ➔ Withdrawn | Trial primary completion date: Jul 2024 ➔ Dec 2022
Enrollment change • Trial completion date • Trial primary completion date • Trial withdrawal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
|